Cpl Life Sciences US

US Staffing within Life Sciences

Close
  • Job Search
    • Physicians
    • Clinical Research
    • Regulatory Affairs
    • Send us your Resume
  • About Us
    • Meet The Team
    • Testimonials
    • Press
    • Contact Us
  • Industry Training
  • Client Services
    • Testimonials
  • Case Studies
  • My Account
Menu

acquisitions

Written by Cpl Life Sciences US
October 18, 2019

Boston firm, Alexion acquires Achillion for $930 million

Achillion Pharmaceuticals Inc. has been purchased by Alexion Pharmaceuticals Inc. of Boston for $930 million, or $6.30 a share, pending approval by Achillion shareholders and regulators. Achillion shareholders will also get an extra dollar a share if the FDA approves Achillion’s Danicopan (for a rare blood disease) and another dollar if a drug in development

Continue Reading

Written by Cpl Life Sciences US
July 12, 2017

Sanofi gets flu vaccines booster with $650M-plus Protein Sciences acquisition

Twice during last year, Sanofi has come up short in high-stakes attempts at top M&A prospects. Now, the drugmaker has finally bagged an acquisition, though not on the scale of its runs for Medivation or Actelion. Sanofi said on Tuesday that it’s picking up Connecticut-based flu vaccine maker Protein Sciences in a deal worth $650

Continue Reading

Written by Cpl Life Sciences US
June 22, 2017

Parexel International to go private after $5 billion deal

The global biopharmaceutical service provider, Parexel, is being snapped up by private equity group Pamplona Capital Management in a deal valued at approximately $5 billion (including debt) marking further consolidation of the contract research sector. The groups have signed a definitive agreement under which Pamplona will acquire all of the outstanding shares of Paraxel for

Continue Reading

Categories

  • Career Advice
  • Company Info
  • Industry news
  • Uncategorized
  • News

Tags

Abbvie achillion acquisitions advertising Alexion Allergan AstraZeneca Biosimilar Biotech BMS Boehringer Ingelheim Boston Breast Cancer Brexit clinical research Clinical Trial clinical trials CMO Conference CPL Physicians Diabetes drug development Elections Eli Lilly FDA graduate academy Health Hep C immuno-oncology J&J JnJ Networking Novartis Novo Nordisk oncology Parexel Pfizer Pharmaceutical Regulatory Roche Sandoz Sanofi Takeda UK US

Like to Talk to a Consultant?

Call or email us directly and find out your next career step:
info@cplphysicians.com or (617) 844-1434



Part of the Cpl Group

Expert Life Science Staffing

Contact Us

Call or email us to find out how we can assist you today

Call Us

Email Us

Our Offices

HEADQUARTERS
Cambridge, Boston,
Call: (617) 844-1434

UK
T: +44 (0)118 9522 799
BELGIUM
T: +32 (0)2 892 3993
GERMANY
T: +49 (0)711 222 54 403
IRELAND
T: +353 (0)144 752 96

© 2017 CPL Physicians — All Rights Reserved
Linked In Twitter Google
Back to Top